Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Adenocarcinoma D000230 166 associated lipids
Agranulocytosis D000380 7 associated lipids
Albuminuria D000419 18 associated lipids
Alzheimer Disease D000544 76 associated lipids
Amnesia D000647 12 associated lipids
Anaphylaxis D000707 35 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Angina Pectoris D000787 27 associated lipids
Angina, Unstable D000789 14 associated lipids
Hypoxia D000860 23 associated lipids
Anthrax D000881 1 associated lipids
Arenaviridae Infections D001117 1 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Arteriosclerosis D001161 86 associated lipids
Arteriosclerosis Obliterans D001162 8 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Arthus Reaction D001183 8 associated lipids
Ascites D001201 25 associated lipids
Asphyxia Neonatorum D001238 4 associated lipids
Asthma D001249 52 associated lipids
Pulmonary Atelectasis D001261 1 associated lipids
Behcet Syndrome D001528 7 associated lipids
Birth Weight D001724 23 associated lipids
Blister D001768 16 associated lipids
Blood Platelet Disorders D001791 12 associated lipids
Body Weight D001835 333 associated lipids
Bovine Virus Diarrhea-Mucosal Disease D001912 2 associated lipids
Brain Diseases D001927 27 associated lipids
Brain Edema D001929 20 associated lipids
Brain Injuries D001930 4 associated lipids
Bronchial Diseases D001982 3 associated lipids
Bronchial Spasm D001986 18 associated lipids
Bronchiectasis D001987 7 associated lipids
Bronchopulmonary Dysplasia D001997 4 associated lipids
Bronchopulmonary Sequestration D001998 3 associated lipids
Burns D002056 34 associated lipids
Burns, Inhalation D002059 4 associated lipids
Carbon Monoxide Poisoning D002249 9 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Central Nervous System Diseases D002493 10 associated lipids
Brain Ischemia D002545 89 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Cholecystitis D002764 8 associated lipids
Cholestasis D002779 23 associated lipids
Cholestasis, Intrahepatic D002780 4 associated lipids
Chromoblastomycosis D002862 2 associated lipids
Cluster Headache D003027 4 associated lipids
Colitis D003092 69 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Colonic Diseases D003108 5 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Conjunctivitis D003231 7 associated lipids
Constriction, Pathologic D003251 8 associated lipids
Contracture D003286 3 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Coronary Disease D003327 70 associated lipids
Coronary Thrombosis D003328 7 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Cystitis D003556 23 associated lipids
Death, Sudden D003645 12 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Dictyocaulus Infections D004022 1 associated lipids
Disseminated Intravascular Coagulation D004211 7 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Duodenal Ulcer D004381 12 associated lipids
Dyslexia D004410 3 associated lipids
Ear Diseases D004427 7 associated lipids
Edema D004487 152 associated lipids
Encephalitis D004660 15 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Epilepsy D004827 35 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Escherichia coli Infections D004927 17 associated lipids
Extravasation of Diagnostic and Therapeutic Materials D005119 3 associated lipids
Fetal Growth Retardation D005317 9 associated lipids
Fever D005334 35 associated lipids
Fibrosis D005355 23 associated lipids
Gastritis D005756 27 associated lipids
Gastroesophageal Reflux D005764 10 associated lipids
Glioma D005910 112 associated lipids
Gliosis D005911 6 associated lipids
Glomerulonephritis D005921 35 associated lipids
Glomerulonephritis, IGA D005922 7 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Heart Arrest D006323 13 associated lipids
Heart Defects, Congenital D006330 20 associated lipids
Cardiomegaly D006332 31 associated lipids
Heart Injuries D006335 6 associated lipids
Hematoma, Subdural D006408 3 associated lipids
Hemolysis D006461 131 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Tokumura A et al. Exogenously added alkylmethylglycerophosphocholine and alkylmethylcarbamylglycerophosphocholine accumulate in plasma membranes more than in intracellular membranes of rabbit platelets. 1997 Chem. Phys. Lipids pmid:9149390
Albert DH et al. Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist. 1997 Eur. J. Pharmacol. pmid:9151941
Sei Y et al. Pentoxifylline decreases brain levels of platelet activating factor in murine AIDS. 1997 Eur. J. Pharmacol. pmid:9151942
FitzGerald GA Cigarettes and the wages of sn-2: oxidized species of PAF in smoking hamsters. 1997 J. Clin. Invest. pmid:9153267
Lehr HA et al. Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking. 1997 J. Clin. Invest. pmid:9153277
Bazan NG and Allan G Signal transduction and gene expression in the eye: a contemporary view of the pro-inflammatory, anti-inflammatory and modulatory roles of prostaglandins and other bioactive lipids. 1997 Surv Ophthalmol pmid:9154273
Bussolati B et al. Modulatory effect of interleukin-10 on the production of platelet-activating factor and superoxide anions by human leucocytes. 1997 Immunology pmid:9155653
Lash GE and Legge M Induction of early pregnancy factor activity in vitro by platelet-activating factor in mice. 1997 J. Reprod. Fertil. pmid:9155726
Ammit AJ and O'Neill C The role of albumin in the release of platelet-activating factor by mouse preimplantation embryos in vitro. 1997 J. Reprod. Fertil. pmid:9155741
Velasquez LA et al. Expression of platelet-activating factor receptor in the hamster oviduct: localization to the endosalpinx. 1997 J. Reprod. Fertil. pmid:9155745
Petersen LJ et al. Platelet-activating factor induces histamine release from human skin mast cells in vivo, which is reduced by local nerve blockade. 1997 J. Allergy Clin. Immunol. pmid:9155831
Froon AM et al. Treatment with the platelet-activating factor antagonist TCV-309 in patients with severe systemic inflammatory response syndrome: a prospective, multi-center, double-blind, randomized phase II trial. 1996 Shock pmid:9156785
El-Shazly AE et al. Immunoregulatory effect of substance P in human eosinophil migratory function. 1996 Immunol. Invest. pmid:9157054
Stengel D et al. Expression of the PAF receptor in human monocyte-derived macrophages is downregulated by oxidized LDL: relevance to the inflammatory phase of atherogenesis. 1997 Arterioscler. Thromb. Vasc. Biol. pmid:9157961
Frostegård J et al. Platelet-activating factor and oxidized LDL induce immune activation by a common mechanism. 1997 Arterioscler. Thromb. Vasc. Biol. pmid:9157962
Ammit AJ and O'Neill C Optimization of a method for deactivation of platelet-activating factor:acetylhydrolase in serum for use in in-vitro fertilization culture media. 1997 Hum. Reprod. pmid:9159443
Walker BA et al. Adenosine A3 receptor expression and function in eosinophils. 1997 Am. J. Respir. Cell Mol. Biol. pmid:9160835
Berends C et al. Inhibition of PAF-induced expression of CD11b and shedding of L-selectin on human neutrophils and eosinophils by the type IV selective PDE inhibitor, rolipram. 1997 Eur. Respir. J. pmid:9163638
Herrero-Beaumont G and Egido J PAF, a potent proinflammatory mediator, looking for its role in the pathogenesis of joint damage. 1997 Ann. Rheum. Dis. pmid:9165991
Napoli C et al. Glycosylation enhances oxygen radical-induced modifications and decreases acetylhydrolase activity of human low density lipoprotein. 1997 Basic Res. Cardiol. pmid:9166989
Chen J and Giris N Species differences in PAF receptor binding in the lungs between hamster and guinea pig. 1997 J Lipid Mediat Cell Signal pmid:9172049
Le Solleu H et al. A pharmacophore for high affinity PAF antagonists. II. Hydrophobicity study using the molecular lipophilicity potential. 1997 J Lipid Mediat Cell Signal pmid:9172050
Shindo K et al. Effect of azelastine hydrochloride on release and production of platelet activating factor in human neutrophils. 1997 Prostaglandins Leukot. Essent. Fatty Acids pmid:9175174
Leoncini G et al. Hyperactivity and increased hydrogen peroxide formation in platelets of NIDDM patients. 1997 Thromb. Res. pmid:9175236
Despotis GJ et al. Effects of platelets and white blood cells and antiplatelet agent C7E3 (Reopro) on a new test of PAF procoagulant activity of whole blood. 1997 Thromb. Res. pmid:9175242
Koyama S et al. Type II pneumocytes release chemoattractant activity for monocytes constitutively. 1997 Am. J. Physiol. pmid:9176245
Lin CN et al. 2',5'-Dihydroxychalcone as a potent chemical mediator and cyclooxygenase inhibitor. 1997 J. Pharm. Pharmacol. pmid:9178190
Vasänge M et al. A sulphonoglycolipid from the fern Polypodium decumanum and its effect on the platelet activating-factor receptor in human neutrophils. 1997 J. Pharm. Pharmacol. pmid:9178195
Kelefiotis D and Vakirtzi-Lemonias C Kinetics of PAF transfer, distribution and metabolism in human blood in vitro. 1997 Life Sci. pmid:9180364
Stotland MA and Kerrigan CL The role of platelet-activating factor in musculocutaneous flap reperfusion injury. 1997 Plast. Reconstr. Surg. pmid:9180723
Salcedo R et al. Endogenous fibronectin of blood polymorphonuclear leukocytes: stimulus-induced secretion and proteolysis by cell surface-bound elastase. 1997 Exp. Cell Res. pmid:9184073
Ephgrave K et al. The role of platelet-activating factor in conscious, normotensive endotoxemia. 1997 J. Surg. Res. pmid:9184676
Bazan HE and Tao Y PAF antagonists as possible inhibitors of corneal epithelial defects and ulceration. 1997 J Ocul Pharmacol Ther pmid:9185044
Mathiak G et al. Platelet-activating factor (PAF) in experimental and clinical sepsis. 1997 Shock pmid:9185238
Okubo Y et al. Inhibitory effects of theophylline and procaterol on eosinophil function. 1997 Intern. Med. pmid:9187566
Lacasse C et al. Platelet-activating factor stimulates interleukin-6 production by human endothelial cells and synergizes with tumor necrosis factor for enhanced production of granulocyte-macrophage colony stimulating factor. 1997 Inflammation pmid:9187959
van der Weiden RM and Wouters JM Infertility may sometimes be associated with non-steroidal anti-inflammatory drug consumption. 1997 Br. J. Rheumatol. pmid:9189067
Chen J and Giri SN Differences in platelet-activating factor receptor mediated Ca++ response between hamster and guinea pig alveolar macrophages. 1997 J. Pharmacol. Exp. Ther. pmid:9190835
Hinterleitner TA et al. Platelet-activating factor contributes to immune cell and oxidant-mediated intestinal secretion. 1997 J. Pharmacol. Exp. Ther. pmid:9190862
Teixeira MM et al. Pertussis toxin shows distinct early signalling events in platelet-activating factor-, leukotriene B4-, and C5a-induced eosinophil homotypic aggregation in vitro and recruitment in vivo. 1997 Blood pmid:9192781
Sharma R et al. Direct effects of platelet-activating factor on glomerular capillary permeability. 1997 Kidney Blood Press. Res. pmid:9192907
Rodriguez-Roisin R Acute severe asthma: pathophysiology and pathobiology of gas exchange abnormalities. 1997 Eur. Respir. J. pmid:9192945
Rocha MF et al. Clostridium difficile toxin A induces the release of neutrophil chemotactic factors from rat peritoneal macrophages: role of interleukin-1beta, tumor necrosis factor alpha, and leukotrienes. 1997 Infect. Immun. pmid:9199444
Lin J et al. Dexamethasone inhibits mucous glycoprotein secretion via a phospholipase A2-dependent mechanism in cultured chinchilla middle ear epithelial cells. 1997 Acta Otolaryngol. pmid:9199527
Liu B et al. Effects of MTX and BN52021 on PAF-induced chemotaxis of PMNs and intraepidermal accumulation of inflammatory cells in guinea pigs. 1996 Chin. Med. J. pmid:9206081
Zhang S et al. [Determination of platelet activating factor and platelet associated IgG in pregnancy-induced hypertension]. 1996 Zhonghua Fu Chan Ke Za Zhi pmid:9206185
Bellone G et al. Bone marrow stroma-derived prolactin is involved in basal and platelet-activating factor-stimulated in vitro erythropoiesis. 1997 Blood pmid:9207433
Hoffman BF et al. Electrophysiologic effects of interactions between activated canine neutrophils and cardiac myocytes. 1997 J. Cardiovasc. Electrophysiol. pmid:9209969
Balestrieri ML et al. The role of platelet-activating factor-dependent transacetylase in the biosynthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine by stimulated endothelial cells. 1997 J. Biol. Chem. pmid:9211886
Svetlov SI et al. Regulation of platelet-activating factor (PAF) biosynthesis via coenzyme A-independent transacylase in the macrophage cell line IC-21 stimulated with lipopolysaccharide. 1997 Biochim. Biophys. Acta pmid:9219895